Plus Therapeutics (NASDAQ: PSTV)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Plus Therapeutics (NASDAQ: PSTV) through any online brokerage.
The latest price target for Plus Therapeutics (NASDAQ: PSTV) was reported by HC Wainwright & Co. on Thursday, February 11, 2021. The analyst firm set a price target for 7.00 expecting PSTV to rise to within 12 months (a possible 1196.06% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Plus Therapeutics (NASDAQ: PSTV) is $0.5401 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Plus Therapeutics.
Plus Therapeutics’s Q2 earnings are confirmed for Thursday, July 21, 2022.
There is no upcoming split for Plus Therapeutics.
Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.